The Hidden Gem in Biopharma: Jazz Pharmaceuticals Surges with Surprising Q4 Performance
Jazz Pharmaceuticals reported a 7.5% increase in Q4 sales, reaching $1.09 billion, surpassing Wall Street expectations. Despite slightly lower full-year revenue guidance, Jazz outperformed
